Chlorambucil,Venetoclax,Obinutuzumab
roche,GSK,abbvie
['venclexta', 'gazyva', 'cll']
#eha22 cll14: 5-yr os still not stat sign but this caught my eye: 72.1% of patients in the venclexta +gazyva did not require another treatment for cll in the five years following initial treatment (hr 0.42 p&lt;0.0001). i d choose this all day every day if i were a cll patient 
Opinions are my own: Former GLG Council Member (Oncology, IO, CAR T) ??Help Save Lives in Ukraine Donate to @Mriya_Aid at https://t.co/21PBkhfRVx ????